Nan Fung Group Holdings »

Maplight Therapeutics shares owned by Nan Fung Group Holdings

Quarter-by-quarter ownership of Maplight Therapeutics (MPLT) shares owned by Nan Fung Group Holdings from 13F filings

Historical chart of Nan Fung Group Holdings investment in Maplight Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Maplight Therapeutics held by Nan Fung Group Holdings consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Maplight Therapeutics by Nan Fung Group Holdings

Quarter filed Position value Share count Share price at filing
2025-12-31 $17M 971k 17.57

More positions owned by Nan Fung Group Holdings

Evommune Com Shs (EVMN)
Maplight Therapeutics (MPLT)
Oculis Holding Ordinary Shares (OCS)
Madrigal Pharmaceuticals (MDGL)
Lb Pharmaceuticals Com Shs (LBRX)
Incyte Corporation (INCY)
Rhythm Pharmaceuticals (RYTM)
Beone Medicines Sponsored Ads (ONC)
Procore Technologies (PCOR)
Cybin Com New (HELP)
Ascendis Pharma A/s Sponsored Adr (ASND)
ACADIA Pharmaceuticals (ACAD)
Recursion Pharmaceuticals In Cl A (RXRX)
D Fluidigm Corp Del (LAB)
Kymera Therapeutics (KYMR)

View all positions for Nan Fung Group Holdings

Top funds holding Maplight Therapeutics

Novo A/S
T. Rowe Price Investment Management
Goldman Sachs Group
Nan Fung Group Holdings
5AM Venture Management
Vanguard Group
Pivotal bioVenture Partners Investment Advisor
Geode Capital Management
Blue Owl Capital Holdings
State Street Corporation
Lazard Asset Management
Board of Trustees of The Leland Stanford Junior University
Freestone Grove Partners
Polygon Management
Bnp Paribas Investment Partners

View all funds holding Maplight Therapeutics